Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The SOCS-1 story.

D Metcalf1

  • 1The Walter and Eliza Hall Institute of Medical Research, Royal Melbourne Hospital, Victoria, Australia.

Experimental Hematology
|January 21, 2000
PubMed
Summary
This summary is machine-generated.

Suppressor of Cytokine Signaling 1 (SOCS-1) is vital for preventing lethal neonatal disease in mice. Loss of SOCS-1 leads to hyperresponsiveness to interferon gamma (IFN-gamma), causing severe health issues.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The SOCS box of suppressor of cytokine signaling-1 is important for inhibition of cytokine action in vivo.

Proceedings of the National Academy of Sciences of the United States of America·2001
Same author

Production of colony-stimulating factors and IL-5 by organs from three types of mice with inflammatory disease due to loss of the suppressor of cytokine signaling-1.

Journal of immunology (Baltimore, Md. : 1950)·2001
Same author

Neutralization of interferon-gamma in neonatal SOCS1-/- mice prevents fatty degeneration of the liver but not subsequent fatal inflammatory disease.

Immunology·2001
Same author

Functional analysis of Asb-1 using genetic modification in mice.

Molecular and cellular biology·2001
Same author

The multi-organ origin of interleukin-5 in the mouse.

Leukemia·2001
Same author

Placental defects and embryonic lethality in mice lacking suppressor of cytokine signaling 3.

Proceedings of the National Academy of Sciences of the United States of America·2001

Area of Science:

  • Immunology
  • Molecular Biology
  • Genetics

Background:

  • SOCS-1 is an intracellular protein that inhibits cytokine signaling pathways, including those mediated by interferon gamma (IFN-gamma).
  • It acts as a negative feedback regulator for signaling initiated by at least eight distinct cytokines via receptors like gp130.
  • SOCS-1 production is transient and inducible upon cytokine stimulation.

Discussion:

  • Mice lacking functional SOCS-1 (SOCS-1-/-) exhibit a lethal neonatal syndrome characterized by liver damage and immune cell infiltration.
  • This syndrome closely resembles the effects of high-dose neonatal IFN-gamma injection.
  • The disease is preventable by anti-IFN-gamma antibodies or by removing the IFN-gamma gene, confirming IFN-gamma's critical role.

Key Insights:

Related Experiment Videos

  • The absence of SOCS-1 does not cause IFN-gamma overproduction but rather a hyperresponsiveness of cells to normal IFN-gamma levels.
  • IFN-gamma is essential for initiating the lethal neonatal disease and mortality in SOCS-1 deficient mice.
  • SOCS-1 plays a crucial role in maintaining immune homeostasis by preventing excessive cytokine signaling.

    • Outlook:

    • Further research is needed to understand the long-term consequences for SOCS-1-/- mice that survive the neonatal period.
    • Loss of SOCS-1 may predispose individuals to other cytokine-mediated diseases due to heightened sensitivity to various signaling pathways.
    • Investigating SOCS-1's role in other immune-related disorders could reveal therapeutic targets.